[Radioactive substances (32P and 89Sr) in the treatment of pain in bone metastases].
In the urological department of the Wilhelminenspital altogether 22 patients with incurable bone pains in metastasizing carcinoma were treated with radioisotopes between 1976 and 1980. 32P and 89Sr were used in a dosage of 3 times 3 mCi and once 1 mCi. A reaction to the therapy could be proved in 46%, in 23% the success could be estimated as very good. Clinic and therapy were discussed with the help of own cases and literature.
D000230:Adenocarcinoma / Q000556:secondary; D000368:Aged; D001859:Bone Neoplasms / Q000473:pathology / Q000532:radiotherapy / Q000556:secondary*; D002277:Carcinoma / Q000556:secondary; D005260:Female; D006801:Humans; D007680:Kidney Neoplasms / Q000473:pathology / Q000532:radiotherapy*; D008297:Male; D009367:Neoplasm Staging; D010166:Palliative Care / Q000379:methods*; D010761:Phosphorus Radioisotopes / Q000627:therapeutic use*; D011471:Prostatic Neoplasms / Q000473:pathology / Q000532:radiotherapy*; D013326:Strontium Radioisotopes / Q000627:therapeutic use*
D010761:Phosphorus Radioisotopes; D013326:Strontium Radioisotopes
Radioaktive Substanzen (32P und 89Sr) in der Schmerzbehandlung bei Knochenmetastasen.